VC  Elm Street Ventures

     Office Locations:

33 Whitney Avenue
New Haven, CT 06510
Phone: 203-401-4201
Fax: 203-401-4235



  • Early
  • Seed



  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device
  • Software & Internet



    Elm Street Ventures' principal strategy is to create and initially operate life sciences companies founded on intellectual property developed at Yale University and other research institutions in the region (from New York City through Southern New England). Elm Street Ventures helps scientists build significant technology companies from the seed and early stages. Its partners include successful serial entrepreneurs and experienced corporate managers, who may serve as the interim CEOs or operating chairmen of a number of the companies formed. While Elm Street Ventures expects to be co-founders of companies in some circumstances, the firm is also interested in hearing from entrepreneurs, scientists, and engineers who have already formed or plan to form new ventures in the life sciences. Elm Street Ventures' investments range from several hundred thousand dollars to $1 million or more, with substantial capital reserved for follow-on investments. The firm will consider companies in the following industries: Life Sciences (including therapeutics, medical devices, diagnostics, research tools and services, materials, healthcare, and healthcare services); Clean technology, with an emphasis on green chemistry; and Information technology including mobile and social web.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Adrian Horotan Principal
    David R. Whittaker MD Venture Consultant
    Michael Sherman PhD Partner
    Rob Bettigole Managing Partner


    Portfolio companies include:

      Accelerated Orthopedic Technologies
        web link

        web link

        web link

        web link

        web link

        web link

        web link

      Iconic Therapeutics
        web link

      Kolltan Pharmaceuticals
        web link

      Occam Sciences
        web link

      P2 Science
        web link

      Retail Optimization
        web link

      Samara Innovations
        web link

        web link

        web link


    Recent News: